Vaccine Critic Robert F. Kennedy Jr. Creates Concerns Among Scientists

RFK Jr. is spearheading an intense cross-agency push for government scientists to examine his theory that vaccines fuel chronic disease, despite White House efforts to reduce his public vaccine criticism ahead of midterms.

Objective Facts

Kennedy is spearheading an intense push across health agencies for government scientists and federal data contractors to examine his long-held theory that vaccines are helping to fuel an epidemic of chronic disease. The effort is being led by Martin Kulldorff, a biostatistician and vaccine safety expert, with career scientists at the FDA and CDC conducting the research alongside contractors providing statistical expertise and access to millions of patient medical records. The work is raising alarms among vaccine scholars who fear Kennedy will use the findings to further erode confidence in vaccines, which the World Health Organization estimates saved 154 million lives over the past half-century. The White House has reduced Kennedy's public presence on vaccine issues ahead of midterm elections amid concerns that his views are unpopular with voters. The research push will cost the CDC alone between $40 million and $50 million.

Left-Leaning Perspective

Left-leaning outlets and public health officials have responded with alarm to Kennedy's behind-the-scenes vaccine inquiry. Authors Demetre Daskalakis, Daniel Jernigan, and Debra Houry published a May 2026 opinion piece in a major news outlet stating that Kennedy and political appointees at HHS and the CDC who share his anti-vaccine views are "undeterred" despite White House pressure to reduce his public presence on vaccine issues. Kayla Hancock, Director of Protect Our Care's Public Health Project, characterized the effort as Kennedy "wasting taxpayer resources on a fishing expedition in search of a shred of data that disagrees with the overwhelming peer-reviewed scientific consensus that vaccines are safe—mainly to prop up lucrative lawsuits that help make his friends and family rich". Left-leaning commentary emphasizes Kennedy's track record of misrepresenting data. Dr. Daniel Jernigan, who oversaw vaccine safety at the CDC until resigning in August, told the New York Times that Kennedy "will continue to try and analyze" data "in a way that will help support the conclusions that he's already made," describing this as "a real problem". The Center for American Progress and other progressive outlets point to recent measles outbreaks in Texas, Utah and South Carolina as evidence of the consequences of undermining vaccines, with expectations of similar events as Kennedy reshapes national health priorities. Left-leaning critics omit or downplay any legitimate scientific debates about vaccine safety monitoring systems and focus instead on Kennedy's alleged financial conflicts of interest and his purported bias in study design. They do not substantially engage with arguments that existing surveillance systems may have limitations or that additional research could be scientifically justified, instead treating such investigations as inherently partisan.

Right-Leaning Perspective

Right-leaning outlets and Trump administration officials have framed Kennedy's vaccine research initiative as a legitimate scientific endeavor. Fox News reported on the research initiative and noted that Martin Kulldorff, the biostatistician leading the effort, co-authored the Great Barrington Declaration in 2020, challenging widespread lockdown policies and advocating alternative public health strategies, presenting his pandemic-era work as credible alternative thinking rather than contrarian ideology. Supporting voices in right-aligned outlets argue there are legitimate gaps in vaccine research. In a report cited on multiple right-leaning platforms, internal medicine physician Clayton J. Baker stated current vaccine research has not adequately addressed questions raised by families, arguing that "the existing research is not designed to—or rather, it is designed not to—identify any such link between vaccines and autism". The Trump administration's official position, articulated by HHS spokesperson Andrew Nixon, contends that Kennedy is "executing on President Trump's commitment to strengthen public health by advancing gold-standard vaccine research" and that failing to probe safety gaps would constitute "gross negligence by an agency charged with protecting public health and rebuilding public trust". Right-leaning coverage downplays or omits the substantial body of peer-reviewed research finding no vaccine-autism link, does not address Kulldorff's involvement in litigation against vaccine manufacturers at $400 per hour, and does not engage with criticisms that comparing vaccinated to unvaccinated populations could yield misleading results due to confounding factors like healthcare access.

Deep Dive

Kennedy's behind-the-scenes vaccine research initiative represents a significant escalation in his use of federal authority to pursue vaccine safety investigations. While the White House has reduced Kennedy's public vaccine criticism ahead of midterm elections—concerned his views are unpopular with voters—Kennedy and political appointees at HHS and CDC who share his anti-vaccine views are reported to remain undeterred. This suggests a disconnect between Trump administration electoral strategy and Kennedy's operational priorities. The specific angle of scientific credibility is where the deepest disagreement emerges. Critics are correct that Martin Kulldorff, the biostatistician leading the research, earned $400 per hour as an expert witness in 2024 litigation against vaccine maker Merck—raising legitimate questions about potential financial incentives. However, supporters correctly note that Kulldorff co-authored the Great Barrington Declaration in 2020, and the New York Times acknowledged he maintains credibility within portions of the scientific community despite controversy surrounding his pandemic-era positions. The methodological concerns are substantive: comparing vaccinated children to unvaccinated children could lead to skewed outcomes, as vaccinated children are more likely to receive regular medical care and thus more likely to receive diagnoses incorrectly attributed to vaccines. What remains unclear is whether Kennedy's inquiry is designed to answer genuine scientific questions about surveillance gaps or to validate predetermined anti-vaccine conclusions. What comes next will be critical: whether the research produces findings that substantially contradict existing peer-reviewed evidence on vaccine safety, how federal health agencies respond if results do not support Kennedy's hypotheses, and whether Congress or courts impose additional constraints on these research efforts as midterms approach and the Trump administration recalibrates vaccine messaging.

OBJ SPEAKING

Create StoryTimelinesVoter ToolsRegional AnalysisPolicy GuideAll StoriesCommunity PicksUSWorldPoliticsBusinessHealthEntertainmentTechnologyAbout

Vaccine Critic Robert F. Kennedy Jr. Creates Concerns Among Scientists

RFK Jr. is spearheading an intense cross-agency push for government scientists to examine his theory that vaccines fuel chronic disease, despite White House efforts to reduce his public vaccine criticism ahead of midterms.

May 21, 2026· Updated May 24, 2026
What's Going On

Kennedy is spearheading an intense push across health agencies for government scientists and federal data contractors to examine his long-held theory that vaccines are helping to fuel an epidemic of chronic disease. The effort is being led by Martin Kulldorff, a biostatistician and vaccine safety expert, with career scientists at the FDA and CDC conducting the research alongside contractors providing statistical expertise and access to millions of patient medical records. The work is raising alarms among vaccine scholars who fear Kennedy will use the findings to further erode confidence in vaccines, which the World Health Organization estimates saved 154 million lives over the past half-century. The White House has reduced Kennedy's public presence on vaccine issues ahead of midterm elections amid concerns that his views are unpopular with voters. The research push will cost the CDC alone between $40 million and $50 million.

Left says: Left-leaning health officials and commentators argue that Kennedy and his anti-vaccine allies continue a "fishing expedition" to manufacture evidence against vaccines despite White House pressure to quiet his vaccine criticism before the midterms.
Right says: Trump administration and right-leaning supporters frame Kennedy's vaccine research as advancing "gold-standard" science and argue that failing to examine safety gaps would constitute negligence in protecting public health.
✓ Common Ground
Some voices on both sides acknowledge that public trust in health institutions has eroded and that rebuilding that trust is a legitimate policy goal, though they deeply disagree on how to achieve it.
Both left and right-leaning observers recognize that vaccine safety monitoring systems exist and that discussion about their adequacy is technically possible, though they dispute whether Kennedy's inquiry is motivated by genuine scientific concern or predetermined conclusions.
Critics on both sides agree that conflicts of interest in vaccine advisory committees are a legitimate concern worthy of scrutiny, though they dispute whether the previous ACIP members had such conflicts and whether Kennedy's replacements have different ones.
Objective Deep Dive

Kennedy's behind-the-scenes vaccine research initiative represents a significant escalation in his use of federal authority to pursue vaccine safety investigations. While the White House has reduced Kennedy's public vaccine criticism ahead of midterm elections—concerned his views are unpopular with voters—Kennedy and political appointees at HHS and CDC who share his anti-vaccine views are reported to remain undeterred. This suggests a disconnect between Trump administration electoral strategy and Kennedy's operational priorities.

The specific angle of scientific credibility is where the deepest disagreement emerges. Critics are correct that Martin Kulldorff, the biostatistician leading the research, earned $400 per hour as an expert witness in 2024 litigation against vaccine maker Merck—raising legitimate questions about potential financial incentives. However, supporters correctly note that Kulldorff co-authored the Great Barrington Declaration in 2020, and the New York Times acknowledged he maintains credibility within portions of the scientific community despite controversy surrounding his pandemic-era positions. The methodological concerns are substantive: comparing vaccinated children to unvaccinated children could lead to skewed outcomes, as vaccinated children are more likely to receive regular medical care and thus more likely to receive diagnoses incorrectly attributed to vaccines. What remains unclear is whether Kennedy's inquiry is designed to answer genuine scientific questions about surveillance gaps or to validate predetermined anti-vaccine conclusions.

What comes next will be critical: whether the research produces findings that substantially contradict existing peer-reviewed evidence on vaccine safety, how federal health agencies respond if results do not support Kennedy's hypotheses, and whether Congress or courts impose additional constraints on these research efforts as midterms approach and the Trump administration recalibrates vaccine messaging.

◈ Tone Comparison

Left-leaning outlets employ terms suggesting deception and financial self-interest—"fishing expedition," "lucrative lawsuits," and emphasis on money-making—while right-leaning outlets use language emphasizing scientific rigor and transparency, with phrases like "gold-standard science" and "bring the childhood immunization schedule in line with gold-standard science". The left frames Kennedy as operating "behind the scenes" to hide his agenda, while the right frames the work as necessary due to whitehouse political pressure.